Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Limonitum Ameliorates Castor Oil-Induced Diarrhoea in Mice by Modulating Gut Microbiota

YL. Ma, BF. Yan, J. Liu, SL. Dai, J. Liu, XX. Wang, F. Fang, SC. Wu, Y. Wang, CY. Xu, Q. Zhao, HB. Wang, DK. Wu

. 2022 ; 68 (4) : 133-141. [pub] -

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23002183

Diarrhoea is a common clinical condition; its pathogenesis is strongly associated with gut microbiota dysbiosis. Limonitum is a well-known traditional Chinese medicine that exerts appreciable benefits regarding the amelioration of diarrhoea. However, the mechanism through which Limonitum ameliorates diarrhoea remains unclear. Here, the efficacy and underlying mechanism of Limonitum decoction (LD) regarding diarrhoea were explored from the aspect of gut microbiota. Castor oil (CO) was used to induce diarrhoea in mice, which were then used to evaluate the effects of LD regarding the timing of the first defecation, diarrhoea stool rate, degree of diarrhoea, diarrhoea score, intestinal propulsive rate, and weight of intestinal contents. The concentrations of short-chain fatty acids (SCFAs), including acetic, propionic, isobutyric, butyric and valeric acids, were analysed by gas chromatography-mass spectrometry (GC-MS). The 16S rRNA high-throughput sequencing technology was applied to evaluate changes in the gut microbiota under exposure to LD. LD was found to effectively ameliorate the symptoms of diarrhoea, and the diversity and relative abundance of gut microbiota were restored to normal levels following LD treatment. Additionally, LD significantly restored the observed reductions in SCFAs. These results provide strong evidence that LD can sufficiently ameliorate diarrhoea in mice by regulating their gut microbiota. The findings presented here highlight that Limonitum may constitute a prospective remedy for diarrhoea.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002183
003      
CZ-PrNML
005      
20230417105327.0
007      
ta
008      
230406s2022 xr da f 000 0|eng||
009      
AR
024    __
$a 10.14712/fb2022068040133 $2 doi
035    __
$a (PubMed)36871169
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Ma, Y. L. $u College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China $u Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, Nanjing, China
245    10
$a Limonitum Ameliorates Castor Oil-Induced Diarrhoea in Mice by Modulating Gut Microbiota / $c YL. Ma, BF. Yan, J. Liu, SL. Dai, J. Liu, XX. Wang, F. Fang, SC. Wu, Y. Wang, CY. Xu, Q. Zhao, HB. Wang, DK. Wu
520    9_
$a Diarrhoea is a common clinical condition; its pathogenesis is strongly associated with gut microbiota dysbiosis. Limonitum is a well-known traditional Chinese medicine that exerts appreciable benefits regarding the amelioration of diarrhoea. However, the mechanism through which Limonitum ameliorates diarrhoea remains unclear. Here, the efficacy and underlying mechanism of Limonitum decoction (LD) regarding diarrhoea were explored from the aspect of gut microbiota. Castor oil (CO) was used to induce diarrhoea in mice, which were then used to evaluate the effects of LD regarding the timing of the first defecation, diarrhoea stool rate, degree of diarrhoea, diarrhoea score, intestinal propulsive rate, and weight of intestinal contents. The concentrations of short-chain fatty acids (SCFAs), including acetic, propionic, isobutyric, butyric and valeric acids, were analysed by gas chromatography-mass spectrometry (GC-MS). The 16S rRNA high-throughput sequencing technology was applied to evaluate changes in the gut microbiota under exposure to LD. LD was found to effectively ameliorate the symptoms of diarrhoea, and the diversity and relative abundance of gut microbiota were restored to normal levels following LD treatment. Additionally, LD significantly restored the observed reductions in SCFAs. These results provide strong evidence that LD can sufficiently ameliorate diarrhoea in mice by regulating their gut microbiota. The findings presented here highlight that Limonitum may constitute a prospective remedy for diarrhoea.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a střevní mikroflóra $7 D000069196
650    _2
$a ricinový olej $7 D002368
650    _2
$a prospektivní studie $7 D011446
650    _2
$a RNA ribozomální 16S $7 D012336
650    _2
$a průjem $7 D003967
655    _2
$a časopisecké články $7 D016428
700    1_
$a Yan, B. F. $u College of Pharmacy, Jiangsu Health Vocational College, Nanjing, China
700    1_
$a Liu, J. $u College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China $u Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, Nanjing, China
700    1_
$a Dai, S. L. $u College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China $u Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, Nanjing, China
700    1_
$a Liu, J. $u 3College of Pharmacy, Jiangsu Health Vocational College, Nanjing, China
700    1_
$a Wang, X. X. $u Chemistry and Bio-medicine Innovation Centre (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China
700    1_
$a Fang, F. $u College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China $u Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, Nanjing, China
700    1_
$a Wu, S. C. $u College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China $u Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, Nanjing, China
700    1_
$a Wang, Y. $u College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China $u Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, Nanjing, China
700    1_
$a Xu, C. Y. $u College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China $u Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, Nanjing, China
700    1_
$a Zhao, Q. $u Geological Survey of Jiangsu Province, Geological Society of Jiangsu Province, Nanjing, China
700    1_
$a Wang, H. B. $u Suzhou Leiyunshang Pharmaceutical Co. Ltd., Suzhou, China
700    1_
$a Wu, D. K. $u College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China $u Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, Nanjing, China
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 68, č. 4 (2022), s. 133-141
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36871169 $y Pubmed
856    41
$u https://fb.cuni.cz/file/6224/fb2022a0016.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20230406 $b ABA008
991    __
$a 20230417105325 $b ABA008
999    __
$a ok $b bmc $g 1920711 $s 1188389
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 68 $c 4 $d 133-141 $e - $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK138 $a Pubmed-20230406
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace